Optimized large-scale production of high titer lentivirus vector pseudotypes.

[1]  N. Mazarakis,et al.  Transduction patterns of pseudotyped lentiviral vectors in the nervous system. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  B. Nuttin,et al.  Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain , 2003, Gene Therapy.

[3]  B. Karolewski,et al.  Comparison of transfection conditions for a lentivirus vector produced in large volumes. , 2003, Human gene therapy.

[4]  V. Madden,et al.  Lentivirus vector purification using anion exchange HPLC leads to improved gene transfer. , 2003, BioTechniques.

[5]  N. Taylor,et al.  IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. , 2003, Blood.

[6]  A. Ganser,et al.  Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography , 2002, Gene Therapy.

[7]  F. Cosset,et al.  Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  I. Martins,et al.  In Vivo Gene Transfer Using a Nonprimate Lentiviral Vector Pseudotyped with Ross River Virus Glycoproteins , 2002, Journal of Virology.

[9]  G. Kobinger,et al.  Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  G. Kobinger,et al.  Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  M. Westphal,et al.  Oncoretrovirus and Lentivirus Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus Glycoprotein: Generation, Concentration, and Broad Host Range , 2002, Journal of Virology.

[12]  F. Cosset,et al.  Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors , 2001, Gene Therapy.

[13]  A. Kingsman,et al.  Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. , 2001, Human molecular genetics.

[14]  M. Prevost,et al.  Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  F. Cosset,et al.  Concentration of viral vectors by co‐precipitation with calcium phosphate , 2001, The journal of gene medicine.

[16]  G. Kobinger,et al.  Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo , 2001, Nature Biotechnology.

[17]  W. Ostertag,et al.  Recombinant Expression of Lymphocytic Choriomeningitis Virus Strain WE Glycoproteins: a Single Amino Acid Makes the Difference , 2001, Journal of Virology.

[18]  R. Zufferey,et al.  Production of High‐Titer Lentiviral Vectors , 2000 .

[19]  W. Uckert,et al.  Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. , 2000, Virology.

[20]  J. Reiser.  Production and concentration of pseudotyped HIV-1-based gene transfer vectors , 2000, Gene Therapy.

[21]  L. Ailles,et al.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences , 2000, Nature Genetics.

[22]  L. Kedes,et al.  A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. , 1999, Journal of molecular and cellular cardiology.

[23]  T. Hope,et al.  Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances Expression of Transgenes Delivered by Retroviral Vectors , 1999, Journal of Virology.

[24]  J. Yee,et al.  Requirements for Efficient Production and Transduction of Human Immunodeficiency Virus Type 1-Based Vectors , 1999, Journal of Virology.

[25]  Hideki Mochizuki,et al.  High-Titer Human Immunodeficiency Virus Type 1-Based Vector Systems for Gene Delivery into Nondividing Cells , 1998, Journal of Virology.

[26]  Fred H. Gage,et al.  Development of a Self-Inactivating Lentivirus Vector , 1998, Journal of Virology.

[27]  Luigi Naldini,et al.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.

[28]  A. Kingsman,et al.  A transient three-plasmid expression system for the production of high titer retroviral vectors. , 1995, Nucleic acids research.

[29]  M. Braddock,et al.  Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells. , 1995, Journal of cell science.

[30]  J. Burns,et al.  A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. Gorman,et al.  Intervening sequences increase efficiency of RNA 3' processing and accumulation of cytoplasmic RNA. , 1990, Nucleic acids research.